Physician profile
Daniel Edward Hatz
NPI 1407174584
$8,743.03
in general payments reported to CMS, 2019-2025
16 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $82.12 · 2021: $1,439 · 2022: $3,248 · 2023: $2,683 · 2024: $886 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513 · Travel and Lodging: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,512.87 |
| Travel and Lodging | $1,461.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,900.04 | 2020-2023 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $2,205.98 | 2022-2025 | Pro, Inspace, Gamma |
| Maxx Orthopedics, INC. | $1,417.08 | 2021-2023 | |
| Conetic Solutions, INC. | $1,244.12 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $711.87 | 2023 | Avenir |
| Vertex Pharmaceuticals Incorporated | $101.01 | 2025 | |
| Orthofix Medical, INC. | $22.36 | 2025 | Accelstim |
| Heron Therapeutics, INC. | $22.13 | 2025 | Zynrelef |
| Abbvie INC. | $21.19 | 2024 | |
| Impel Pharmaceuticals INC. | $15.08 | 2023 | Trudhesa |
| Exact Sciences Corporation | $14.59 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $13.83 | 2024 | Jardiance |
| Amgen INC. | $13.74 | 2024 | Prolia, Evenity |
| Dexcom, INC. | $13.57 | 2023 | Dexcom G6 Transmitter |
| Halozyme INC | $13.48 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $12.96 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.